Team:Heidelberg/Notebook/Sensing Group/Cloning

From 2008.igem.org

(Difference between revisions)
(Sensing - Cloning strategy)
(Sensing - Cloning strategy)
Line 132: Line 132:
=== LuxS ===
=== LuxS ===
-
LuxS is amplified from the ''V. harveyi'' genome with primers LuxQa/LuxQc. Subsequently the product is cloned into the pTr99alpha plasmid at the NcoI and BamHI sites and transformed into DH5a competent cells.
+
LuxS is amplified from the ''V. harveyi'' genome with primers LuxSa/LuxSb. Subsequently the product is cloned into the pTr99alpha plasmid at the NcoI and BamHI sites and transformed into DH5a competent cells.
=== LuxP ===
=== LuxP ===
Line 138: Line 138:
=== Fusion receptor ===
=== Fusion receptor ===
 +
First LuxQ will be amplied with primers LuxQa/LuxQc from the ''V. harveyi'' genome. The fragment will then be cloned into pTrc99alpha plasmid at the NcoI and BamHI site. Subsequently this construct will be used as template for constructing the Fusion receptors.
=== References ===
=== References ===
[1] Dong, X.; Stothard, P.; Forsythe, I. J. & Wishart, D. S., '''PlasMapper: a web server for drawing and auto-annotating plasmid maps''', Nucleic Acids Res, Vol. 32, pp. W660-W664, 2004
[1] Dong, X.; Stothard, P.; Forsythe, I. J. & Wishart, D. S., '''PlasMapper: a web server for drawing and auto-annotating plasmid maps''', Nucleic Acids Res, Vol. 32, pp. W660-W664, 2004

Revision as of 21:15, 26 October 2008

Contents

Sensing - Cloning strategy

The core part of the sensing project is the construction of the LuxQ-Tar chimeric receptor, which enables the E. coli killer bacteria to chemotactically respond to a AI-2 gradient and detect prey cells. The quorum-sensing system is amplified from the V. harveyi genome while the Tar receptor is from E. coli. On the one hand LuxS needs to be cloned and transformed into one cell type, to make them produce and secrete AI-2. On the other hand the periplasmic ligand binding domain is fused to the cytoplasmic domain of Tar and cloned on one plasmid together with LuxP which is necessary for AI-2 binding. Generally, needed restriction sites for cloning are introduced via the PCR primer. In silico cloning was performed in SerialCloner, Vector maps were designed with PlasMapper [1].

pTrc99a for LuxS and LuxQ cloning
pDK48 for cloning of fusion
pBAD33 used in Swarm-Assays


LuxS

LuxS is amplified from the V. harveyi genome with primers LuxSa/LuxSb. Subsequently the product is cloned into the pTr99alpha plasmid at the NcoI and BamHI sites and transformed into DH5a competent cells.

LuxP

LuxP will be amplied with primers LuxPc/LuxPd from the V. harveyi genome. Then the product will be cloned into native pDK48. After the construction of the LuxQ-Tar Fusion gene in pDK48 plasmid, the LuxP will also be introduced in the pDK48 plasmid at SalI and NotI sites. The whole construct of pDK48 will be transformed into our killer cell.

Fusion receptor

First LuxQ will be amplied with primers LuxQa/LuxQc from the V. harveyi genome. The fragment will then be cloned into pTrc99alpha plasmid at the NcoI and BamHI site. Subsequently this construct will be used as template for constructing the Fusion receptors.


References

[1] Dong, X.; Stothard, P.; Forsythe, I. J. & Wishart, D. S., PlasMapper: a web server for drawing and auto-annotating plasmid maps, Nucleic Acids Res, Vol. 32, pp. W660-W664, 2004